Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk?

The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations ...

Valisure says the FDA should recall Sanofi’s Zantac and all other ranitidine products “to protect the American public from further exposure to the potentially carcinogenic properties of ...

A probable carcinogen that prompted the recall of several versions of blood pressure-lowering pills has been detected in the heartburn drug Zantac and its generic versions, the Food and Drug ...

The FDA is also advising consumers taking OTC ranitidine to stop taking any tablets or liquid they currently have, dispose of them properly and not buy more.

Amidst recalls over the popular heartburn OTC medication Zantac over suspected carcinogens, the FDA has released a list of safe antacid alternatives.

"CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice," a spokesperson for the brand wrote in a press release.

The FDA announced the recall of over-the-counter ranitidine tablets, prescription capsules and syrup due to unacceptable levels of N-nitrosodimethylamine or NDMA.

The move marks the first time the FDA has suggested drug makers should recall the ranitidine heartburn pills since opening a probe several weeks ago.

Shares of Sanofi [: sny] fell 1.78% in trading on Wednesday after the Food and Drug Administration (FDA) issued a voluntary recall of Sanofi's Zantac, a prescription and over-the-counter heartburn ...

The US Food and Drug Administration said on Friday that it has learned that some heartburn medicines – including Zantac – contain low levels of a nitrosamine impurity known as N ...